ICOPER: Vascular Structure, Vascular Function and Vascular Aging in Adults Diagnosed With Persistent COVID

Sponsor
Fundacion para la Investigacion y Formacion en Ciencias de la Salud (Other)
Overall Status
Recruiting
CT.gov ID
NCT05819840
Collaborator
(none)
300
1
9.8
30.7

Study Details

Study Description

Brief Summary

The ICOPER study aims to analyze the structure, vascular function, vascular aging and determining factors in 300 adults diagnosed with Persistent Covid in the field of Primary Health Care.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Objective: To analyze the structure, the vascular function, the vascular aging and the determining factors in adults with a diagnosis of Persistent Covid and the differences by gender.

    Design: Cross-sectional descriptive observational study. Setting: The study will be carried out at the Salamanca Primary Care Research Unit (APISAL). Study Subjects: The study includes the basis of the Persistent Covid Monographic consultation in the Internal Medicine Service of the University Hospital of Salamanca and the subjects with the diagnosis of Persistent Covid in the MEDORA Primary Care clinical history. Thus, 300 subjects have been obtained who are diagnosed with Persistent Covid, who meet the diagnostic criteria established by the Spanish Society of General and Family Physicians and sign the informed consent.

    Measurements: The variables reflected in the Integrated Assistance process for the Care of People Affected by SARS CoV-2 of the Junta de Castilla y León will be collected, to evaluate the functional status of the patient and persistent symptoms, their impact on activities of daily life and quality of life of patients with Persistent Covid and the perception of their health. Lifestyles (diet, physical activity, tobacco and alcohol), psychological factors and cognitive impairment will be collected using validated questionnaires, and physical activity will be objectively measured with a 7-day pedometer. Vascular structure and function will be analyzed by measuring the thickness of the carotid intima media (Sonosite Micromax); pulse wave analysis and carotid-femoral pulse wave velocity (VOPcf) (Sphygmocor System). Cardio Ankle Vascular Index (CAVI), ankle-brachial pulse wave velocity (VOPbt) and ankle-brachial index (Vasera VS-2000®). Vascular aging will be calculated using the 10 and 90 percentiles of the VOPcf and the VOPbt. Demographic, analytical variables and to assess retinal, cardiac, renal, cerebral vascular lesion and cardiovascular risk will be collected.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Vascular Structure, Vascular Function and Vascular Aging in Adults Diagnosed With Persistent COVID. ICOPER Study.
    Actual Study Start Date :
    Mar 9, 2023
    Anticipated Primary Completion Date :
    Sep 30, 2023
    Anticipated Study Completion Date :
    Dec 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Pulse Wave Velocity [1 year]

      Measurement by SphygmoCor System (meters/seg)

    Secondary Outcome Measures

    1. Carotid intima-media thickness (IMT) [1 year]

      Measurement by Sonosite Micromax Ultrasound (mm)

    2. Cardio Ankle Vascular Index (CAVI) [1 year]

      Measurement by Vasera device 2000 (not units)

    3. Physical Activity [1 year]

      World Questionnaire on Physical Activity (GPAQ)

    4. Eating habits [1 year]

      Mediterranean Diet Adherence PREDIMED Questionnaire

    5. Smoking [1 year]

      Measurement by a questionnaire of four questions adapted from the WHO MONICA study

    6. Drinking habits [1 year]

      Measurement by a frequency alcohol questionnaire (units/day)

    7. Psychological factors [1 year]

      Goldberg Anxiety and Depression Scale

    8. Cognitive evaluation [1 year]

      Measurement by Montreal Cognitive Assessment (MOCA) (points). Range: 0-30 points. A score of 26 points or above is considered normal.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    The inclusion criteria are based on the WHO clinical definition of Persistent Covid established by international Delphi consensus, together with patients, their representatives and experts from the five continents. Persistent Covid is the condition of individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months after onset, with symptoms that last at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, and cognitive dysfunction, and generally have an impact on daily functioning. Symptoms may be of new onset after initial recovery from an acute episode of Covid-19 or persist from the initial illness. Symptoms may also fluctuate or relapse over time.

    Exclusion Criteria:

    As exclusion criteria: subjects in a terminal situation, inability to travel to health centers, presenting a history of cardiovascular disease (ischemic heart disease or cerebrovascular disease) or a glomerular filtration rate of less than 30%.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Primary Care Research Unit of Salamanca (APISAL) Salamanca Spain 37005

    Sponsors and Collaborators

    • Fundacion para la Investigacion y Formacion en Ciencias de la Salud

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Fundacion para la Investigacion y Formacion en Ciencias de la Salud
    ClinicalTrials.gov Identifier:
    NCT05819840
    Other Study ID Numbers:
    • GRS2501/B/22
    First Posted:
    Apr 19, 2023
    Last Update Posted:
    Apr 19, 2023
    Last Verified:
    Apr 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Apr 19, 2023